A Race Against Blindness Announces $1 Million Research Commitment

Today, we are proud to share one of the most significant milestones in the history of A Race Against Blindness. Thanks to the incredible support of our donors, sponsors, and community, we have committed $1 million toward inherited retinal disease research through a partnership with the Foundation Fighting Blindness and the RD Fund . As many of you know, A Race Against Blindness was founded after our son Luke was diagnosed with retinitis pigmentosa caused by Bardet-Biedl Syndrome (BBS). Since then, our mission has been simple: move promising therapies from concept to clinic as quickly as possible for children and families facing vision loss. This commitment will support two exciting areas of research: The RD Fund , which invests in companies developing treatments for inherited retinal diseases, including gene-agnostic approaches that may benefit patients regardless of the specific gene causing their condition. Dr. Thomas Mendel's research at The Ohio State University Wexner Medical Center , which is exploring a new method of delivering retinal gene therapy that could one day improve t